Return to homepagePandemic Pact

to expand manufacturing capacity of Covid-19 direct antigen RDTs to better serve demand in low and middle income countries.

Grant number: INV-023198

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020

  • Known Financial Commitments (USD)

    $400,000

  • Funder

    Gates Foundation

  • Research Location

    United States of America

  • Lead Research Institution

    Access Bio, Inc.

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

N/A